Drug Type Monoclonal antibody |
Synonyms hPA 0661, hPA0661 |
Target |
Mechanism CDH17 antagonists(Cadherin-17 antagonists), ITGA2&ITGB1 agonists(Integrin alpha2/beta1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Colorectal Carcinoma | Preclinical | ES | 23 Oct 2023 |